KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Interest Expenses: 2011-2015

Historic Interest Expenses for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $1.2 million.

  • Biocryst Pharmaceuticals' Interest Expenses rose 1.97% to $1.2 million in Q3 2015 from the same period last year, while for Sep 2015 it was $5.2 million, marking a year-over-year increase of 5.08%. This contributed to the annual value of $5.0 million for FY2014, which is 4.60% up from last year.
  • According to the latest figures from Q3 2015, Biocryst Pharmaceuticals' Interest Expenses is $1.2 million, which was down 4.98% from $1.3 million recorded in Q2 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Interest Expenses peaked at $1.3 million during Q1 2015, and registered a low of $289,000 during Q2 2011.
  • In the last 3 years, Biocryst Pharmaceuticals' Interest Expenses had a median value of $1.2 million in 2015 and averaged $1.2 million.
  • Data for Biocryst Pharmaceuticals' Interest Expenses shows a peak YoY surged of 301.38% (in 2012) over the last 5 years.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Interest Expenses stood at $1.2 million in 2011, then surged by 301.38% to $1.2 million in 2012, then climbed by 0.43% to $1.2 million in 2013, then increased by 5.80% to $1.3 million in 2014, then rose by 1.97% to $1.2 million in 2015.
  • Its Interest Expenses stands at $1.2 million for Q3 2015, versus $1.3 million for Q2 2015 and $1.3 million for Q1 2015.